Form D Explorer

Inspect source fieldsReport a record issue

Form D — BioLattice Ophthalmics, Inc,

0002125596-26-000001 · filed Mar 30, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$2,500,000
Reported amount sold
$575,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
BioLattice Ophthalmics, Inc,
CIK
2125596
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2023
Address
2929 Arch Street
Philadelphia, Pennsylvania 19104
Phone
267 481 5423

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗